May 2026
Beijing Biote Pharmaceut... Market Share Analysis for May 2026
History - the past days
2004.09 Beijing Biote Pharmaceutical Co., ltd was incorporated.
2005.11 Clinical trial completed for Leuprorelin Acetate microspheres sustained release for injection.
2009.07 Leuprorelin Acetate microspheres sustained release for injection was approved by China FDA, licence
Industry: N/A
Beijing Biote Pharmaceutical Co. (including company regionals)
See more website traffic and engagement information- biotepharma.com
Beijing Biote Pharmaceutical Co. Revenue up to May 2026 is 15M - 25M
revenue generated by Beijing Biote Pharmaceutical Co. top domains
Beijing Biote Pharmaceutical Co. top domains revenue over 3 years
Revenue for Beijing Biote Pharmaceutical Co. top domains
Total visits to Beijing Biote Pharmaceutical Co.'s top domains
Understand Beijing Biote Pharmaceutical Co. market share and potential market reach.
Total visits last 3 months
Subsidiaries Breakdown
Avg. visit duration in Beijing Biote Pharmaceutical Co.'s top domains
Analyze Beijing Biote Pharmaceutical Co. engagement metrics.
Average visit duration last 3 months
Subsidiaries Breakdown
Avg. pageviews on Beijing Biote Pharmaceutical Co.'s top domains
See how Beijing Biote Pharmaceutical Co. keep users engaged, nurture their interest, and encourage them to take the next step.
Average page views last 3 months
Subsidiaries Breakdown
